Our ‘raison d’être’ is to support people in leading healthy and happy lives, without resorting to pharmaceutical medication unless absolutely vital. Although we advocate the idiom “An ounce of prevention is better than a pound of cure“, Igennus only exists because of the unfortunate truth that there are millions of people in the UK alone with an inflammatory-related disease or condition.
Most people only begin to truly appreciate the importance of their health when it’s been compromised and yet health is fundamental to our enjoyment of life. Thus, we are here for two reasons: firstly, to provide people with effective, science-based natural therapeutic supplements to avoid sole reliance on pharmaceutical medication; secondly, we endeavour to provide people with accurate, up-to-date nutrition science and information that is both easy to understand and simple to put into practice – extending to areas such as diet and lifestyle, because prevention is key.
“An ounce of prevention is better than a pound of cure…”
Pioneering EPA as a therapeutic active
As the UK leader in the therapeutic application of omega-3 fatty acids, we recognise that our information and advice sometimes directly counter other ‘established’ textbook dietary and nutrition materials. The reality is that much information is actually often misinformation – out-of-date science that is slowly and gradually being clarified or retracted. We’ve long known about the therapeutic actions and potential for EPA (we formulated our first patented EPA-only supplement Vegepa over ten years ago!) and yet the studies and science take years to filter out to mainstream awareness. So Igennus is pioneering, educating and attempting to correct the confusing and mixed messages and obsolete studies that continue to be promoted and taught.
Whilst we continue to fly the flag for EPA science in the UK supplements industry, pioneering researchers and clinicians worldwide have been using EPA-only fish oil with tremendous success for over a decade. Meta-analyses have also shown the isolated benefits of EPA, distinct from DHA, in neurodevelopmental disorders, other aspects of cardiovascular health, and mental health disorders including depression and schizophrenia. Igennus stands firm in its position on EPA science, knowing that its benefits and the supporting evidence are getting stronger each day.
Europe has been slow to catch on to the evolving lipid science, yet progress is rapidly being made in the USA, where EPA is a registered prescription medicine for the treatment of high triglycerides. Now that EPA exists in medication form, companies have started to introduce EPA-only and higher EPA:DHA ratio supplements because consumer demand is being driven and a commercial justification has been found. In other words, many companies won’t take the risky and innovative step towards EPA-only fish oil until they are satisfied that there is enough market potential. This is where Igennus stands out; we don’t follow consumer trends, we follow science and what we believe to be the most effective formulation for a specific health outcome. We expect to have company in a few years’ time, when others take the safer decision to introduce ‘me too’ products into this currently niche area.
“Igennus is pioneering, educating and attempting to correct the mixed messages and obsolete studies that continue to be promoted and taught.”
Despite the uninformed doubt from naysayers, we remain committed to the firm science and encouraged by the tremendous support and feedback from our customers. We know EPA makes a difference to a wide range of health conditions and to the lives of the people who take it regularly. Thousands of people take our omega-3 EPA supplements for a range of conditions; for some who continue with medication they are an essential co-therapy, while others gradually reduce reliance on drugs and manage their condition naturally.
We cannot predict the future but we are confident that EPA science will become established and more accepted over the next decade and that it will help support tens of thousands – hopefully hundreds of thousands – worldwide to improve their health. At Igennus we are agile in our approach, always embracing change and new learning; we promise to remain science-led in our bid to provide health-conscious and concerned individuals with effective, natural nutrition supplements and even more support for a greater range of conditions seen in Western populations.
“…we are confident that EPA science will become established and more accepted over the next decade and that it will help support tens of thousands worldwide to improve their health.”